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Abstract
Introduction: International depression screening guidelines in heart failure (HF) are partly based on depression treatment
efficacy from randomized controlled trials (RCTs). Our aim was to test the external validity of depression RCT criteria in a
sample of real-world HF patients.
Methods: HF patients admitted to 3 hospitals in South Australia were referred to a HF psychologist if not already receiving
current psychiatric management by psychologist or psychiatrist elsewhere. Screening and referral protocol consisted of the
following; (a). Patient Health Questionnaire $10; (b). Generalized Anxiety Disorder Questionnaire $7); (c). positive response
to 1 item panic attack screener; (d). evidence of suicidality. Patients were evaluated against the most common RCT exclusion
criteria personality disorder, high suicide risk, cognitive impairment, psychosis, alcohol or substance abuse or dependency,
bi-polar depression.
Results: Total 81 HF patients were referred from 404 HF admissions, and 73 were assessed (age 60.6613.4, 47.9% female).
Nearly half (47%) met at least 1 RCT exclusion criterion, most commonly personality disorder (28.5%), alcohol/substance
abuse (17.8%) and high suicide risk (11.0%). RCT ineligibility criteria was more frequent among patients with major
depression (76.5% vs. 46.2%, p,.01) and dysthymia (26.5% vs. 7.7%, p = .03) but not significantly associated with anxiety
disorders. RCT ineligible patients reported greater severity of depression (M= 16.665.0 vs. M= 12.967.2, p = .02) and were
higher consumers of HF psychotherapy services (M= 11.564.7 vs. M= 8.564.8, p = .01).
Conclusion: In this real-world sample comparable in size to recent RCT intervention arms, patients with depression
disorders presented with complex psychiatric needs including comorbid personality disorders, alcohol/substance use and
suicide risk. These findings suggest external validity of depression screening and RCTs could serve as a basis for level A
guideline recommendations in cardiovascular diseases.
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Introduction
Depression has gained widespread research attention with
respect to prognosis of heart diseases including heart failure (HF)
[1]. A meta-analysis by Rutledge et al. [2] suggested that the
prevalence of clinical depression was 22% in HF, thus substantially
higher than community prevalence estimates for populations free
from heart failure [3]. It has been consistently shown that
depression doubles the risk of major cardiac events and death in
patients with documented HF [2,4,5], increases healthcare costs
[6], significantly impairs quality of life [7–9], impairs self-care
ability [10] and impacts upon participation in HF disease-
management strategies [11]. Consequently, depression identifica-
tion and management is emphasized in international cardiology
guidelines [12–15], HF treatment guidelines [16] and HF self-
management recommendations [17].
Though a number of studies have applied routine depression
screening protocols to improve recognition of depression [18–27] a
paucity of information exists regarding the ensuing mental health
management strategies initiated within cardiology settings from a
positive depression-screen [22,28–31]. Thombs and colleagues
systematic reviews confirm that a number of issues regarding
routine screening remain unclear [28,29]. As the utility for
depression screening alone in reducing depression and cardiovas-
cular morbidity has not been established [22], randomised,
controlled trials (RCTs) provide Level A empirical evidence to
guide clinical practice for depression management in HF [2,32].
For example, the Safety and Efficacy of Sertraline for Depression
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in Patients with Chronic Heart Failure trial was designed to
facilitate easy translation into clinical practice [33]. Unfortunately,
however, the extant depression RCT evidence in HF [32–36] has
not been subjected to tests of external and ecological validity and
therefore, the implications for clinical practice are not known [37].
Moreover, if external validity of depression RCTs is not
established then unrealistic expectations regarding depression
treatment response may be fostered among clinicians and patients
alike [38]. Complicating these matters further, the American
Heart Association guidelines recommend comprehensive assess-
ment of other mental disorders such as anxiety [12] which are
present in 30% of RCT patients with positive depression screen
[39]. Yet Hasnain and colleagues [22] also emphasize the lack of
guidance for individualized depression treatment plans when such
comorbidity is present. Consequently, underestimation of the
complexity of real-world mental health treatment needs may
hamper concerted efforts to implement depression screening
guidelines [12,13,16,17] and integrate depression management
into HF clinical practice [19,40,41].
The topical nature of routine depression and anxiety screening
[28,29] suggests it is timely to examine the practical implemen-
tation of integrated mental health care within real-world HF
settings [30] subsequent to guideline based routine depression-
screening initiatives. This study reports on referrals to a HF-
specific psychologist generated from routine depression and
anxiety screening in three public hospitals in Adelaide, South
Australia. The following research questions will be answered:
1. To what extent are real-word HF-patients with depression
covered by the inclusion and exclusion criteria of RCTs on
depression in HF patients?
2. Do RCT ineligible patients differ from RCT eligible patients
with respect to demographic and clinical characteristics?
3. What are the prevalence rates of various depression and
anxiety disorders among HF patients referred for integrated




This study received ethics approval and all participants
provided written and informed consent prior to assessment
(Human Research Ethics Committee of The Queen Elizabeth
Hospital, Lyell McEwin Hospital and Royal Adelaide Hospital
#HREC/12/TQEHLMH/188). Between April 2011 and June
2012 patients with verified HF admission were managed by
specialist HF nurses in a HF self-management program (HFSMP)
[17] at three South Australian hospitals (Queen Elizabeth
Hospital, Royal Adelaide Hospital, Lyell McEwin Hospital).
During this period specialist HF nurses routinely screened patients
with validated questionnaires and referred patients to the HFSMP
psychologist when either of the following criteria were met; (a).
depression symptoms were in the clinically significant range
(Patient Health Questionnaire (PHQ-9) $10); (b). anxiety
symptoms were in the clinically significant range (Generalized
Anxiety Disorder (GAD-7) $7); (c). patients had evidence of panic
attack (N.B. questionnaires described further below). (d). there was
evidence of suicidality (PHQ or identified by nurse). Median time
between referral and assessment was 20 days. A flow chart of
participants through the study is shown in Figure 1.
HFSMP and Consent Process
Referred patients were contacted by telephone to schedule the
initial mental health assessment and all facets of HFSMP care was
provided at no cost. The HFSMP was community based, delivered
flexibly at home visit, hospital site, or prior to weekly HFSMP
exercise classes at Hampstead Rehabilitation Hospital. Ineligibility
criteria for psychologist referral was not having cardiologist
verified HF or currently receiving psychology and/or psychiatrist
support elsewhere.
Patients who consented to standard HFSMP psychology
assessment were free to refuse treatment at any time in accordance
with ethical guidelines and government primary health care
protocols. Patients not desiring the HFSMP psychology assessment
(n = 5) were provided with alternative counselling arrangements
including psychiatrist referral, local psychologist support and tele-
counselling. Refusal did not impinge on standard cardiology care.
HFSMP psychology was withdrawn in cases when patients
transitioned to a palliative care team and the associated mental
health supports. Patients requiring acute psychiatric care were
managed by the treating psychologist in collaboration with the 24
hour South Australian Mental Health Emergency Triage Service
for Community and Older Persons (Acute Crisis Intervention
Service).
Psychological Assessment
Referred patients repeated the depression and anxiety ques-
tionnaire at the psychologist intake assessment and again before
each subsequent psychologist appointment to verify symptom
response to treatment. The PHQ-9 [42] is a 9 item depression
questionnaire covering major depression disorder criteria demar-
cated by DSM-IV [3]. Respondents endorse items based on the
previous two-weeks on a scale of 0 ‘‘not at all’’ to 3 ‘‘nearly every
day.’’ PHQ scores $10 warrant further evaluation according to
the American Heart Association guidelines [12] and have
favorable sensitivity and specificity for detection of depression
disorder in heart disease populations [43].
Patients also completed an 8 item questionnaire regarding
anxiety (Generalized Anxiety Disorder-7, 7 items (GAD-7); and a
one-item panic screener ‘‘In the last 4 weeks, have you had an anxiety
attack – suddenly feeling fear or panic?’’) [44–46]. The GAD-7 is a 7
item anxiety questionnaire covering Generalized Anxiety Disorder
criteria demarcated by DSM-IV [3] and GAD-7 scores $7
warrant further evaluation [46]. The single-item panic disorder
screener also showed favorable sensitivity and specificity in
detection of panic disorder amongst medical and psychosomatic
medicine populations [47]. The anxiety measures were selected in
addition to depression screening as the American Heart Associ-
ation [12] guidelines advocate comprehensive assessment of
anxiety disorders. Also, anxiety disorders are highly prevalent in
heart diseases and predict higher rates of cardiovascular morbidity
and mortality in patients with heart disease [48–54].
Patients were assessed with the Structured Clinical Interview for
DSM-IV Axis-I and AXIS-II disorders [55,56]. The SCID is a
widely validated interview with favourable psychometric proper-
ties. Psychologist diagnoses were verified by two senior clinical
psychologists once per month.
Comparison with RCT Exclusion Criteria
Comparison of the present community treatment sample
against RCT exclusion criteria focussed on depression interven-
tions as there are no known anxiety disorder interventions in HF
patients. Ineligibility for RCT was determined from the recent
systematic review of depression interventions in HF reported by
Woltz and colleagues [32]. Woltz et al. [32] evaluated 23
Mental Health Needs in Heart Failure Patients
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experimental and quasiexperimental HF trails (Total N = 3,564
patients) reporting depression symptom change from a range of
interventions. Here we focussed solely on the six RCTs that
evaluated either antidepressant or psychotherapy (i.e. cognitive-
behavioural therapy, relaxation, mindfulness stress reduction)
[33,36,57–61]. Ineligibility of our real world patients was
determined against the six most common RCT exclusion criteria
extracted from the included trials in Woltz et al [31]:
1. personality disorder [33,36,58,61]: SCID diagnosis of a
personality disorder
2. suicide risk [33,36,57,59]; score of PHQ item 9$2, verified at
structured interview
3. cognitive impairment [33,36,57,61]: Mini Mental State
Examination #23, verified dementia or developmental disor-
der
4. current or past psychosis [33,36,57,59,61]: SCID diagnosis of a
psychotic episode/disorder
5. active alcohol/substance abuse or dependency [33,57,59–61]:
SCID diagnosis of alcohol/substance abuse or dependency
6. current or past bi-polar [33,59,61]: SCID diagnosis of bi-polar
disorder
Statistical Analyses
Data analysis was performed with SPSSH 19.0 (SPSS Inc.,
Chicago, IL). Descriptive comparisons between RCT eligible and
ineligible groups employed the independent samples t-test, and the
chi-square statistic with Fisher’s exact test as appropriate. All
statistical tests were two-tailed, an alpha value p,.05 was
considered statistically significant. This exploratory study pertains
to RCT criteria validation and we have therefore not adjusted for
multiple comparisons [62].
Figure 1. Flow chart of patients through the study.
doi:10.1371/journal.pone.0085928.g001
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Results
During the study period 81 patients were referred to HF mental
health care, 8 were not included (did not want support (n = 5), HF
death prior to mental health assessment (n = 2), receiving
psychology treatment elsewhere (n = 1). This left a sample of 73
patients whom underwent mental health assessment and psycho-
therapy as appropriate (Flow Chart shown in Figure 1.).
Prevalence of RCT Eligibility by Depression Criteria
Nearly half (46.6%) of assessed patients would be excluded from
RCTs according to the six standard exclusion criteria (Table 1).
The most common RCT exclusion criterions were personality
disorder (28.8%), alcohol/substance abuse or dependency (17.8%)
and suicide risk (11.0%). Analysis comparing the proportion of
each RCT eligibility criteria between patients with depression
disorder (major depression or dysthymia 6 any anxiety) with those
without depression disorder showed that patients with a mood
disorder were more likely to meet at least 1 RCT exclusion criteria
(60.4% vs. 29%, p,.001), particularly personality disorder (41.7%
vs. 4.0%, p,.001) and alcohol/substance abuse or dependency
(25.0% vs. 4.0%, p = .03). The proportion of RCT exclusion
criteria by depression diagnosis is depicted in Figure 2.
Demographic Descriptives According to RCT Eligibility
Comparison of the RCT eligible and ineligible patients with
respect to demographics and comorbidities is shown in Table 2
(age M = 60.6613.4, 47.9% female, 8.2% Indigenous Australian).
RCT ineligible patients were more likely to have chronic pain
documented in medical records (29.4% vs. 10.3%, p = .04).
Ineligible patients were also less likely to have had a prior
myocardial infarction (32.4% vs. 59.0%, p = .03), and there were
no other significant differences.
Psychosocial Descriptives According to RCT Eligibility
Comparison of the RCT eligible and ineligible patients with
respect to clinical psychiatric factors is shown in Table 3. RCT
ineligible patients were more likely to receive anti-depressant
treatment including amitriptyline (58.8% vs. 23.1%, p,.01) and
reported greater severity of depression (PHQ M = 16.665.0 vs.
12.967.2, p = .02). RCT ineligible patients were also higher
consumers of psychotherapy sessions during the HFSMP
(M = 11.564.7 vs. 8.564.8, p = .01).
Mental Health Prevalence Rates
The prevalence of depression and anxiety disorders is shown in
Table 4 and stratified according to RCT eligibility. The most
common disorders were major depression (60.3%), GAD (57.5%),
panic disorder (52.1%) and social phobia (27.4%). Among the
patientswithamajordepressionordysthymiadiagnosis, 8/48did not
meet comorbid anxiety diagnosis. Comparison of patients based on
RCT ineligibility showed an association with major depression
(76.5% vs. 46.2%, p,.01) and dysthymia (26.5% vs. 7.7%, p = .03)
and was not significantly associated with anxiety disorders.
Discussion
This study reports the mental health status subsequent to
depression and anxiety screening among HF patients. Psychological
assessment suggested that patients commonly presented with
emotional disorders other than depression including GAD and panic
disorder, consistent with other research [54,63–67]. However,
psychiatric history would preclude nearly half of these HF patients
from participation in contemporary depression RCTs based on six
standard exclusion criteria identified from Woltz et al’s [32]
systematic review. RCT ineligibility was highest amongst patients
with depression disorders. Also, RCT ineligible patients reported
greater severity of depression, chronic pain and were higher
consumers of psychotherapy. Together the findings indicate that
routine depression screening protocols may underestimate or not
align with the real world psychiatric needs in HF. Consequently the
extant depression treatment evidence may not even apply to half of
cardiovascular patients referred for further psychiatric assessment.
A number of effective treatments for depression have been
reported [68] though effects on suicidality are less clear [69]. The
results here belie the assumption that depression is the only
psychosocial factor for which HF patients require mental health
care. These findings thus support the recent examples of routine
anxiety screening in general cardiovascular patients [18,64,65].
Hasnain and colleagues [22] highlighted the absence of clinical
guidance for individualized treatment plans when comorbid
anxiety is present. The extent to which comorbid anxiety affects
depression treatment response is unknown even though 30% of
cardiac patients with a positive depression screen in a recent RCT
met anxiety disorder criteria [39]. Clearly a limitation to mental
health service provision and routine screening protocols among
cardiovascular patients is the paucity of evidence-based treatments
for individual anxiety disorders. Encouragingly, Shemesh et al
showed that brief imaginal exposure and cognitive-behavioural
therapy for PTSD after a cardiovascular event was associated with
no marked increase in blood pressure, pulse and mean arterial
pressure [70]. However safety of exposure-based anxiety treat-
ments has not been demonstrated for GAD or panic [53]. These
anxiety disorders were among the most common anxiety disorders
prevalent here and elsewhere [54,63] and may raise cardiovascular
risk [71]. Nevertheless, psychotropic agents are utilized in early
psychiatric intervention for anxiety disorders and also those
Figure 2. Proportion of standard RCT exclusion criteria met by
HF patients according to depression status (yes vs. no).
doi:10.1371/journal.pone.0085928.g002
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Personality disorder 21 (28.8) 1 (4.0) 20 (41.7) .001*
High suicide risk 8 (11.0) 3 (12.0) 5 (10.4) 1.0
Cognitive impairment 3 (4.1) 2 (8.0) 1 (2.1) .27
Current or past psychosis 2 (2.7) 0 2 (4.2) .54
Active alcohol/substance abuse or
dependency
13 (17.8) 1 (4.0) 12 (25.0) .03*
Current or past bi-polar 2 (2.7) 0 2 (4.2) .54
Met any RCT exclusion criteria 34 (46.6) 5 (20.0) 29 (60.4) .001*
Number of RCT exclusion criteria met ,.01*
1 23 (31.5) 3 (12.0) 20 (41.7)
2 7 (9.6) 2 (8.0) 5 (10.4)
3 4 (5.5) 0 4 (8.3)
RCT, randomized controlled trial.
*p,.05.
doi:10.1371/journal.pone.0085928.t001







Demographic and comorbidity factors
Female 35 (47.9) 18 (46.2) 17 (50.0) .74
Age, M(SD) 60.6 (13.4) 60.7 (13.9) 60.6 (13.1) .98
Lives on own 19 (26.0) 8 (20.5) 11 (32.4) .25
Disability Pension 22 (30.1) 11 (28.2) 11 (32.4) .70
Indigenous Australian 6 (8.2) 4 (10.3) 2 (5.9) .68
Current divorce/bereavement 8 (11.0) 3 (7.7) 5 (14.7) .46
NYHA Class II 26 (35.6) 17 (43.6) 9 (26.5) .35
III 39 (53.4) 18 (46.2) 39 (53.4)
IV 8 (11.0) 4 (10.3) 8 (11.0)
Left ventricular ejection fraction 33.9 (12.1) 34.2 (11.6) 33.5 (12.9) .82
Prior myocardial infarction 34 (46.6) 23 (59.0) 11 (32.4) .03*
Atrial fibrillation 25 (34.2) 11 (28.2) 14 (41.2) .24
Coronary artery bypass 19 (26.0) 13 (33.3) 6 (17.6) .13
Valve repair/replacement 12 (16.4) 4 (10.3) 8 (23.5) .13
Biventricular pacemaker 11 (15.1) 7 (17.9) 4 (11.8) .46
Implanted cardiac defibrillator 19 (26.0) 13 (33.3) 6 (17.6) .13
Stroke/cerebrovascular accident 9 (12.3) 6 (15.4) 3 (8.8) .40
Chronic obstructive pulmonary disease 22 (30.1) 11 (28.2) 11 (32.4) .70
Renal disease 26 (35.6) 15 (38.5) 11 (32.4) .59
Diabetes 38 (52.1) 21 (58.3) 17 (45.9) .29
Hypertension 50 (68.5) 27 (75.0) 23 (62.2) .24
Hypercholesterolemia 34 (46.6) 15 (41.7) 19 (51.4) .41
Tobacco Smoking 31 (42.5) 18 (46.2) 13 (38.2) .50
Body mass index kg/m2 .35 25 (24.2) 11 (28.2) 14 (41.2) .24
Sleep apnea 13 (17.8) 5 (12.8) 8 (23.5) .23
Chronic Pain 14 (9.2) 4 (10.3) 10 (29.4) .04*
NYHA, New York Heart Association; RCT, randomized controlled trial.
*p,.05.
doi:10.1371/journal.pone.0085928.t002
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psychiatric disorders which were RCT exclusions (i.e. alcohol/
substance abuse, psychosis and bi-polar depression).
The current findings should not detract from the importance of
prior RCT studies [32–36] and aspects of methodological rigour
other than the six external validity criteria evaluated here.
Application ofappropriateexclusion criteriaareessential to maintain
internal validity. Other reasons justifying exclusion based on
psychiatric criteria include ethical access to more appropriate
treatment and reducing heterogeneity [72]. Diagnostic comorbidity
also serves as a source of bias in depression treatment efficacy RCTs
[73].
The current findings should thus serve to raise awareness
regarding psychiatric illness complexity and comorbidity, partic-
ularly as treatment-resistant depression increases cardiovascular
risk [74,75]. Here, RCT ineligibility was primarily associated with
depression disorders. Patients with mood disorder were signifi-
cantly more likely to have personality disorders and active
alcohol/substance abuse or dependency. Recently it was also
documented that treatment seeking panic disorder patients also
reported high rates of active alcohol/substance abuse and
personality disorders [76]. The findings support the necessity of
comorbidity assessment by qualified professionals after a positive
depression screen [12]. Indeed, the clinical importance of such
assessments are bolstered by findings that the functional aspects of
HF do not correlate with suicide risk [77], whereas personality
disorders, anxiety and depression are more established factors that
increase suicide risk [78,79].
The strength of this study was comprehensive psychological
assessment after a routine depression and anxiety screening initiative
in ambulatory HF patients thus facilitating mental health care
tailored to individual patient needs. This study is presented with
several limitations that temper the generalizability of these findings.
Firstly, the use of anxiety questionnaires may have elicited more
referrals for patients with comorbid anxiety-depression such as GAD
and panic disorder [64,65]. The referral of panic disorder in
particular may correspond to the tendency to focus on dyspnea
symptoms in HF treatment [80]. Secondly, ethical constraints
precluded an evaluation of HF patients that were not routinely
screened and/or not referred. Thus there was no comparison of the
prevalence of those constituent variables for RCT eligibility in the
general HF population. Reports also suggest approximately 27% of
cases are not examined in international routine depression screening
Table 3. Comparison of RCT eligible and ineligible patients on clinical psychiatric characteristics.
Clinical Psychiatric Factors Total N(%) N=73 RCT Eligible N=39 RCT Ineligible N=34 P
Psychotherapy sessions 9.8 (4.8) 8.5 (4.8) 11.5 (4.7) .01*
Past suicide attempt 13 (17.8) 5 (12.8) 8 (23.5) .23
No past psychiatric care 53 (72.6) 30 (76.9) 23 (67.6) .44
Medical records depression 15 (20.5) 5 (12.8) 10 (29.4) .08
Medical records missing depression diagnosisa 39 (53.4) 18 (46.2) 21 (61.8) .18
Anti-depressant 29 (39.7) 9 (23.1) 20 (58.8) ,.01*
PHQ-9 total M(SD) 14.7 (6.5) 12.9 (7.2) 16.6 (5.0) .01*
Any SCID anxiety disorder 52 (71.2) 26 (66.7) 26 (76.5) .36
Medical records missing anxiety diagnosisa 42 (57.5) 21 (53.8) 21 (61.8) .50
Current anxiolytic 21 (28.8) 8 (20.5) 13 (38.2) .10
GAD-7 M(SD) 12.6 (6.7) 12.3 (7.1) 13.0 (6.4) .67
Panic-Screener 28 (38.4) 13 (33.3) 15 (44.1) .35
GAD, Generalized Anxiety Disorder; PHQ, Patient Health Questionnaire; RCT, randomized controlled trial.
*p,.05.
aMedical records depression and medical records anxiety inclusive of diagnoses that conflicts with psychologist SCID assessment. Medical records missing depression or
anxiety diagnosis evaluates medical record comorbidity lists and hospital discharge summaries in preceding 6 months prior to assessment with the SCID diagnosis.
doi:10.1371/journal.pone.0085928.t003
Table 4. Prevalence of depression and anxiety disorders in heart failure patients referred for psychiatric care.
SCID Diagnosis Total N(%) N=73 RCT Eligible N=39 RCT Ineligible N=34 P
Major Depression 44 (60.3) 18 (46.2) 26 (76.5) ,.01*
Dysthymia 12 (16.4) 3 (7.7) 9 (26.5) .03*
Panic +- agoraphobia 38 (52.1) 17 (43.6) 21 (61.8) .12
Generalized anxiety disorder 42 (57.5) 19 (48.7) 23 (67.6) .10
Post-traumatic stress disorder 14 (19.2) 5 (12.8) 9 (26.5) .14
Obsessive-compulsive disorder 5 (6.8) 3 (7.7) 2 (5.9) 1.0
Social phobia 20 (27.4) 8 (20.5) 12 (35.3) .16
Adjustment disorder 14 (19.2) 9 (25.0) 5 (13.5) .21
RCT, randomized controlled trial; SCID, Structured Clinical Interview.
*p,.05.
doi:10.1371/journal.pone.0085928.t004
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protocols [19]. Thirdly, it was not known whether there was a
selection bias in referrals given the under-representation of patients
with cognitive impairment [81]. Fourthly, the sample size, compa-
rable or larger than most intervention arms in recent depression
RCTs evaluated byWoltz et al [32], was potentially too small to draw
broad conclusions regarding the psychiatric treatments needs and
screening suggestions of HF patients generally. Fifthly, the pragmatic
aspects of routine screening in HF need to be considered within the
regional context by contrast to other cardiology settings and
international experiences [18,19,22,30,64,65,82]. These findings
from the current HFSMP may not generalise to other hospitals and it
is unknown whether depression screening in conjunction with other
management strategies in HF might beneficially impact depression
remission rates. Finally, the potential for Type I errors is a limitation
and as such will require confirmation in independent cohorts.
In conclusion, implementation of routine depression screening
protocols in cardiology settings may underestimate the severity
and complexity of psychiatric needs in HF such as comorbid
personality disorders, alcohol/substance use, suicide risk and
anxiety disorders. Application of six standard exclusion criteria
suggested that the extant RCT evidence may not apply to half of
HF patients referred for psychiatric care. Further investigation into
external validity of depression RCTs in cardiology settings is
recommended to better reflect typical HF patient needs [83].
These findings make the case for a specific focus on external
validity of RCTs and depression screening protocols as basis for
level A guideline recommendations.
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